| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Connaughton Bernadette is a Director at HALOZYME THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $2.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 2,000 | $70.25 | $140,500.00 | -4.7% | -11.4% | - | |
| Dec 1, 2025 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 829 | $71.60 | $59,356.40 | -1.9% | +2.6% | - | |
| Nov 10, 2025 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 2,000 | $68.48 | $136,960.00 | -4.4% | +18.3% | - | |
| Oct 1, 2025 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 2,000 | $75.24 | $150,481.00 | -2.2% | -9.7% | - | |
| Sep 2, 2025 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 4,000 | $73.68 | $294,736.24 | -2.7% | -7.1% | - |